Bromazine

Not to be confused with Promazine.

Bromazine

Clinical data
MedlinePlus	a682065
Routes of administration	Oral
ATC code	R06AA01 (WHO)
Pharmacokinetic data
Bioavailability	High
Protein binding	96%
Metabolism	Mostly hepatic (CYP-mediated), also renal
Elimination half-life	1 to 4 hours
Identifiers
IUPAC name 2-[(4-bromophenyl)-phenylmethoxy]-N,N-dimethylethanamine
CAS Number	1808-12-4 Y 1808-12-4
PubChem CID	2444
IUPHAR/BPS	7132
DrugBank	DB01237 Y
ChemSpider	2350 Y
UNII	202J683U97
ChEBI	CHEBI:59177 Y
ChEMBL	ChEMBL1201245 N
CompTox Dashboard (EPA)	DTXSID6022688
ECHA InfoCard	100.003.854
Chemical and physical data
Formula	C17H20BrNO
Molar mass	334.251 g/mol g·mol−1
3D model (JSmol)	Interactive image
SMILES Brc1ccc(cc1)C(OCCN(C)C)c2ccccc2
InChI InChI=1S/C17H20BrNO/c1-19(2)12-13-20-17(14-6-4-3-5-7-14)15-8-10-16(18)11-9-15/h3-11,17H,12-13H2,1-2H3 Y Key:NUNIWXHYABYXKF-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

Bromazine (trade names Ambrodyl, Ambrodil and others), also known as bromodiphenhydramine, is an antihistamine and anticholinergic. It is a halogenated form of diphenhydramine and in many respects is somewhat stronger than the parent compound. The other three halogenated diphenhydramine derivatives are used in research and chlorodiphenhydramine is also marketed with iododiphenhydramine being a much less common pharmaceutical.